A detailed history of Spotlight Asset Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Spotlight Asset Group, Inc. holds 6,886 shares of PFE stock, worth $176,625. This represents 0.14% of its overall portfolio holdings.

Number of Shares
6,886
Previous 7,066 2.55%
Holding current value
$176,625
Previous $196,000 2.04%
% of portfolio
0.14%
Previous 0.14%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$25.26 - $29.6 $4,546 - $5,328
-180 Reduced 2.55%
6,886 $192,000
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $83,780 - $96,206
3,236 Added 84.49%
7,066 $196,000
Q2 2023

Aug 09, 2023

BUY
$36.12 - $41.79 $138,339 - $160,055
3,830 New
3,830 $140,000
Q3 2022

Nov 18, 2022

SELL
$43.76 - $53.42 $289,734 - $353,693
-6,621 Closed
0 $0
Q3 2021

Oct 28, 2021

BUY
$39.25 - $50.42 $7,379 - $9,478
188 Added 2.92%
6,621 $285,000
Q2 2021

Aug 11, 2021

BUY
$35.91 - $40.68 $9,264 - $10,495
258 Added 4.18%
6,433 $252,000
Q1 2021

Apr 07, 2021

SELL
$33.49 - $37.77 $103,316 - $116,520
-3,085 Reduced 33.32%
6,175 $224,000
Q4 2020

Feb 08, 2021

SELL
$33.47 - $42.56 $37,888 - $48,177
-1,132 Reduced 10.89%
9,260 $341,000
Q3 2020

Oct 30, 2020

BUY
$31.75 - $37.25 $107,791 - $126,463
3,395 Added 48.52%
10,392 $381,000
Q2 2020

Jul 23, 2020

SELL
$30.12 - $36.54 $17,439 - $21,156
-579 Reduced 7.64%
6,997 $229,000
Q1 2020

Apr 13, 2020

BUY
$27.03 - $38.62 $2,703 - $3,861
100 Added 1.34%
7,576 $247,000
Q4 2019

Apr 13, 2020

BUY
$32.92 - $37.36 $246,109 - $279,303
7,476 New
7,476 $265,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Spotlight Asset Group, Inc. Portfolio

Follow Spotlight Asset Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spotlight Asset Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Spotlight Asset Group, Inc. with notifications on news.